LYST Gene Chediak-Higashi Syndrome Genetic Test
At DNA Labs UAE, we offer the LYST Gene Chediak-Higashi Syndrome Genetic Test at a cost of AED 4400.0. This test is used to diagnose Chediak-Higashi syndrome (CHS), a rare genetic disorder that affects multiple systems in the body.
Test Details
The LYST gene is associated with CHS. CHS is an autosomal recessive disorder that affects the immune system and nervous system. Our Next-Generation Sequencing (NGS) technology allows for the analysis of the LYST gene to identify any mutations or variants that may be present.
Components
- Test Name: LYST Gene Chediak-Higashi Syndrome Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information
Prior to the test, a Genetic Counselling session is conducted to gather the clinical history of the patient. This includes drawing a pedigree chart of family members affected with CHS and the LYST gene.
Uses of the Test
NGS genetic testing for CHS can be used to:
- Confirm a diagnosis in individuals with suspected CHS based on their clinical symptoms.
- Perform carrier testing in individuals with a family history of CHS.
- Conduct prenatal testing in families at risk of having a child with CHS.
Benefits of the Test
The results of NGS genetic testing for CHS can:
- Guide medical management and treatment decisions for individuals with CHS.
- Provide valuable information for genetic counseling and family planning purposes.
Important Considerations
It’s important to note that NGS genetic testing may not detect all possible mutations or variants in the LYST gene. The interpretation of test results can also be challenging. Therefore, it is crucial to consult with a healthcare professional or genetic counselor who specializes in genetic testing and interpretation to fully understand the implications of the test results.
Test Name | LYST Gene Chediak-Higashi syndrome Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for LYST Gene Chediak-Higashi syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LYST Gene Chediak-Higashi syndrome NGS Genetic DNA Test gene LYST |
Test Details |
The LYST gene is associated with a rare genetic disorder called Chediak-Higashi syndrome (CHS). CHS is an autosomal recessive disorder that affects multiple systems in the body, including the immune system and the nervous system. Next-generation sequencing (NGS) genetic testing can be used to analyze the LYST gene and identify any mutations or variants that may be present. This type of testing allows for the simultaneous analysis of multiple genes, making it a powerful tool for diagnosing genetic disorders like CHS. NGS genetic testing for CHS can help confirm a diagnosis in individuals with suspected CHS based on their clinical symptoms. It can also be used for carrier testing in individuals with a family history of CHS or for prenatal testing in families at risk of having a child with CHS. The results of NGS genetic testing for CHS can help guide medical management and treatment decisions for individuals with the disorder. It can also provide valuable information for genetic counseling and family planning purposes. It’s important to note that NGS genetic testing may not detect all possible mutations or variants in the LYST gene, and the interpretation of test results can sometimes be challenging. Therefore, it is crucial to consult with a healthcare professional or genetic counselor who specializes in genetic testing and interpretation to fully understand the implications of the test results. |